Dr. M. Anne Fahrni earned her M.S. and Ph.D. degrees in organic chemistry from Northwestern University under the tutelage of Lyrica inventor Professor Richard Silverman. Dr. Fahrni began her professional career working in research and development for leading startup biopharmaceutical companies. Her research included regenerative medicine and treatments for cancer, obesity, and neurological disease.
Following her early work in R&D, Dr. Fahrni held a number of roles, including research fellow at the Centers for Disease Control and Prevention in Atlanta, where she conducted research involving virus proteomics, among other projects.
In 2004, Dr. Fahrni expanded her career to include patent application preparation and prosecution and patent portfolio management. She was registered to practice before the U.S. Patent and Trademark Office in 2005 and worked as a scientific advisor and patent practitioner at law firms in the Atlanta area for several years. She joined Wood IP as a senior patent agent in 2016.
Dr. Fahrni has experience in patent preparation and prosecution in a wide range of technical areas, including chemical, biotechnology, pharmaceuticals, material science, medical devices, information technology, and mechanical arts. Her work also includes conducting freedom-to-operate and infringement analysis and IP-related due diligence.
Dr. Fahrni has been active with a number of professional organizations such as National Association of Patent Practitioners (NAPP), Georgia IP Alliance (GIPA), Women in Bio (WIB), and Chiefs in Intellectual Property (ChIPs).